Ethane

Ethane

SCHEMBL3685478

CC.CCOC(=O)COc1ccc(CCCO)cc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.56
NPSR1 Q6W5P4 1/20 0.56
PPARA Q07869 3/20 0.53
PPARG P37231 1/20 0.53
CYP4F2 P78329 2/20 0.53
CYP4A11 Q02928 2/20 0.53
LTA4H P09960 1/20 0.48
EPHX2 P34913 1/20 0.48
KDM4E B2RXH2 3/20 0.47
HSD17B10 Q99714 2/20 0.47
ALDH1A1 P00352 2/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
POLB P06746 1/20 0.46
HTT P42858 1/20 0.46
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508337 0.98 GAA (0.57) GAANPSR1PPARAPPARGCYP4F2
SCHEMBL6375038 0.89 CYP4F2 (0.66) GAANPSR1PPARAPPARGCYP4F2
SCHEMBL11817150 0.88 PPARA (0.63) GAANPSR1PPARAPPARGKDM4E
SCHEMBL12869146 0.87 PPARA (0.69) GAANPSR1PPARAPPARG
SCHEMBL28405319 0.85 PPARA (0.71) GAANPSR1PPARAPPARGALDH1A1
SCHEMBL15922116 0.85 PPARA (0.71) GAANPSR1PPARAPPARGALDH1A1
SCHEMBL2292200 0.84 PPARA (0.55) GAANPSR1PPARAPPARGKDM4E
Hydrochloric Acid SCHEMBL28797126 0.84 GAA (0.55) GAANPSR1PPARAPPARGKDM4E
SCHEMBL1431250 0.83 CYP4A11 (0.57) PPARACYP4F2CYP4A11LTA4HEPHX2
SCHEMBL8321862 0.83 GAA (0.64) GAANPSR1PPARAPPARGCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7655641-B2 Sulfonamide derivatives as PPAR modulators ELI LILLY AND COMPANY (US) 2010-02-02 US disclosed
EP-1597248-B1 SULFONAMIDE DERIVATIVES AS PPAR MODULATORS LILLY CO ELI (US) 2007-12-26 EP disclosed
US-20060257987-A1 Ppar modulators ELI LILLY AND COMPANY 2006-11-16 US disclosed
US-20060217433-A1 Sulfonamide derivatives as ppar modulators ELI LILLY AND COMPANY (US) 2006-09-28 US disclosed
EP-1660428-A1 PPAR MODULATORS ELI LILLY AND COMPANY (US) 2006-05-31 EP disclosed
EP-1597248-A2 SULFONAMIDE DERIVATIVES AS PPAR MODULATORS ELI LILLY AND COMPANY (US) 2005-11-23 EP disclosed
WO-2005019151-A1 PPAR MODULATORS ELI LILLY AND COMPANY (US) 2005-03-03 WO disclosed
WO-2004073606-A2 SULFONAMIDE DERIVATIVES AS PPAR MODULATORS ELI LILLY AND COMPANY (US) 2004-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217433-A1 Sulfonamide derivatives as ppar modulators PPARD, PPARA, PPARG GAA 975/4885NPSR1 466/4885PPARA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.